Chronic rubidium does not prevent dopamine receptor supersensitivity

J. Bannet; R. P. Ebstein; M. Hershkowitz; R. H. Belmaker

doi:10.1159/000117912

Chronic rubidium does not prevent dopamine receptor supersensitivity

J. Bannet, R. P. Ebstein, M. Hershkowitz, R. H. Belmaker

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Unlike lithium, chronic rubidium does not prevent the halopridol-induced increase in spiperone binding. Moreover, unlike other antidepressants, chronic rubidium does not reduce dihydroalprenolol binding.

Original language	English
Pages (from-to)	281-283
Number of pages	3
Journal	Neuropsychobiology
Volume	8
Issue number	6
DOIs	https://doi.org/10.1159/000117912
State	Published - 1 Jan 1982
Externally published	Yes

ASJC Scopus subject areas

Neuropsychology and Physiological Psychology
Psychiatry and Mental health
Biological Psychiatry

Access to Document

10.1159/000117912

Cite this

@article{182aec7bd6b74824b0a12a113fa717e6,

title = "Chronic rubidium does not prevent dopamine receptor supersensitivity",

abstract = "Unlike lithium, chronic rubidium does not prevent the halopridol-induced increase in spiperone binding. Moreover, unlike other antidepressants, chronic rubidium does not reduce dihydroalprenolol binding.",

author = "J. Bannet and Ebstein, {R. P.} and M. Hershkowitz and Belmaker, {R. H.}",

year = "1982",

month = jan,

day = "1",

doi = "10.1159/000117912",

language = "English",

volume = "8",

pages = "281--283",

journal = "Neuropsychobiology",

issn = "0302-282X",

publisher = "S. Karger AG",

number = "6",

}

TY - JOUR

T1 - Chronic rubidium does not prevent dopamine receptor supersensitivity

AU - Bannet, J.

AU - Ebstein, R. P.

AU - Hershkowitz, M.

AU - Belmaker, R. H.

PY - 1982/1/1

Y1 - 1982/1/1

N2 - Unlike lithium, chronic rubidium does not prevent the halopridol-induced increase in spiperone binding. Moreover, unlike other antidepressants, chronic rubidium does not reduce dihydroalprenolol binding.

AB - Unlike lithium, chronic rubidium does not prevent the halopridol-induced increase in spiperone binding. Moreover, unlike other antidepressants, chronic rubidium does not reduce dihydroalprenolol binding.

UR - http://www.scopus.com/inward/record.url?scp=0020371460&partnerID=8YFLogxK

U2 - 10.1159/000117912

DO - 10.1159/000117912

M3 - Article

AN - SCOPUS:0020371460

SN - 0302-282X

VL - 8

SP - 281

EP - 283

JO - Neuropsychobiology

JF - Neuropsychobiology

IS - 6

ER -

Chronic rubidium does not prevent dopamine receptor supersensitivity

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this